Edition:
United Kingdom

Cesca Therapeutics Inc (KOOL.OQ)

KOOL.OQ on NASDAQ Stock Exchange Capital Market

2.86USD
8 Dec 2017
Change (% chg)

$0.08 (+2.88%)
Prev Close
$2.78
Open
$2.81
Day's High
$2.86
Day's Low
$2.73
Volume
9,630
Avg. Vol
20,606
52-wk High
$6.43
52-wk Low
$2.45

Chart for

About

Cesca Therapeutics Inc. is clinical-stage biotechnology company. The Company develops and markets integrated cellular therapies and delivery systems. The Company is engaged in developing and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and... (more)
No analyst recommendations are available for .

Overall

Beta: -0.75
Market Cap(Mil.): $45.06
Shares Outstanding(Mil.): 9.95
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Cesca Therapeutics Announces Proposed Public Offering Of Common Stock

* CESCA THERAPEUTICS INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage:

28 Nov 2017

BRIEF-Cesca Therapeutics appoints Joe Balagot as senior vice president of corporate development

* Cesca Therapeutics appoints healthcare investment banking veteran Joe E. Balagot as senior vice president of corporate development Source text for Eikon: Further company coverage:

22 Nov 2017

BRIEF-Cesca Therapeutics reports quarterly loss per share $0.24

* Cesca Therapeutics announces financial results for the three months ended September 30, 2017 and provides corporate update

14 Nov 2017

BRIEF-Cesca Therapeutics ‍receives Notice of Allowance for U.S. patent application covering a novel method of cell separation​

* Cesca Therapeutics Inc - ‍receives Notice of Allowance for U.S. patent application covering a novel method of cell separation​ Source text for Eikon: Further company coverage:

03 Oct 2017

BRIEF-Cesca Therapeutics announces distribution agreement with Boyalife WSN

* Cesca Therapeutics announces international distribution agreement with Boyalife WSN Ltd.

24 Aug 2017

BRIEF-Cesca Therapeutics announces issuance of new cellular processing patent

* Cesca Therapeutics announces issuance of new cellular processing patent poised to revolutionize CAR-T cell manufacturing Source text for Eikon: Further company coverage:

28 Jul 2017

BRIEF-Cesca Therapeutics says acquires cell processing systems of SynGen

* Cesca therapeutics acquires the cell processing systems of syngen under asset acquisition agreement

10 Jul 2017

Earnings vs. Estimates